Hybridomas from mice immunized with baboon endogenous virus (BaEV) from A204(M7) cells produced several antiviral monoclonal antibodies and, in addition, antibodies D-12 and E-4, which appeared to be virus specific because they reacted with BaEV but not with Mason-Pfizer virus or RD-114 virus. However, they also bound to human virus-free cells, and they did not recognize BaEV from bat or canine host cells. Cell membrane targets for these antibodies comigrated with an 18,000-dalton protein, which may contain specific determinants of BaEV receptors since antibody masking of these cell sites prevented BaEV but not MasonPfizer virus or RD-114 virus adsorption. However, RD-114 virus interfered with BaEV adsorption. Thus, the two viral receptors must We previously immunized mice with semipurified baboon endogenous virus (BaEV) which had been synthesized in the human chronically infected A204(M7) cell line. We prepared monoclonal antibodies A-6 and C-9, which neutralize BaEV and are directed at two very close or similar determinants of the glycoprotein (gp) 70, whereas the nonneutralizing antibody B-9 corresponds to another gp epitope. Antibody F-12 is directed at an 18,000-dalton protein detected in disrupted virions (5) . We found that the latter antibody also reacted with a similar polypeptide of RD-114 virus, whereas the anti-gp antibodies were strictly BaEV specific. In addition, we selected antibodies D-12 and E-4, which were not virus specific since they reacted with virusfree cells. However, in a solid-phase radioimmunoassay, these antibodies bound strongly to semipurified BaEV. This indicated either that semipurified virus particles used for mouse immunization and in the radioimmunoassay contained random host cell contaminants or that a more specific host cell determinant is physiologically incorporated within the virus particle, e.g., at the time of maturation. We show that the cell sites recognized by antibodies D-12 and E-4 are two neighboring determinants which are located within a specific receptor for BaEV only present in human cells, and we discuss the possibility that portions of the cell receptor may be integrated within the virus particles or at least firmly attached to them. The antibodies to BaEV receptors are also useful for studying the distribution of these specific receptors in various human tissues and cell lines.
MATERIALS AND METHODS
Viruses, cells, and antibodies. Five cell lines chronically infected with retroviruses were used in this study. The human A204(M7) and the bat CCL-88-M7 cells produced the M7 strain of BaEV, the dog thymus Fcf2th-BILN cells produced the BILN strain of this virus, the human cells produced the feline virus, and clone 7 of the monkey foreskin cells 940C3 synthesized Mason-Pfizer virus (MP-MV). Virus-free corresponding cells were available for the first four lines cited, but not for the 940C3 line. Vero cells were used as control virus-free monkey cells. The biological activity of viruses in the cell supernatants was quantitated by the number of syncytia formed by BaEV on RSa cells and by RD-114 virus on RSa or KC cells (5, 17) . Other cell lines were those routinely used in many laboratories, including the diploid human fibroblasts MRC5, the human B lymphoblast cell lines NC37 and Raji, the T lymphoblast Molt line, the mouse cells L929, and the rat cells NRK. Suspensions of peripheral blood lymphocytes and of fetal cells as well as of syncytiotrophoblastic cells from human term placenta were prepared as described previously (18) . Monoclonal antibodies A-6, C-9, and B-9 directed against the gp7O of BaEV, F-12 directed at an internal viral polypeptide of 18,000 daltons, and the antibodies D-12 and E-4 directed against host cell components were prepared in this laboratory. Mas 1532 and Mas 018b monoclonal antibodies were bought from SeraLab Ltd., Crawley Down, Sussex, England. The first antibody was provided in the ascite form and is an immunoglobulin G2a (IgG2a) specific for the 43,000-dalton gp chain of the HLA-A, -B, and -C antigens, and the second antibody was the supernatant from hybridoma cultures and is an IgG2a directed against 12 microglobulin. Antisera against HeLa and NC37 cells were from rabbits immunized in our laboratory.
Antibody Serological detection on nitrocellulose. (i) Antigens. Baboon endogenous virus (strain M7) was concentrated from the culture supernatant of A204-or CCL-88-virus producing cells as described previously (5) and purified by isopycnic centrifugation on a continuous 4 to 36% metrizamide gradient at 110,000 x g for 4 h. Cellular membranes (9) were prepared from monolayers of control or M7-producing A204 human cells and CCL-88 bat cells. The preparation of the P50 fraction was carried out as described by Garber et al. (7) , except that dithiothreitol was omitted from the homogenizing buffer. The protein concentration of these antigens, suspended in 10 mM Tris-hydrochloride (pH 7.4)-10 4 M phenylmethylsulfonyl fluoride-100 U of Trasylol per ml, was determined by the method of Bradford (2).
(ii) Electrophoresis and transfer. Samples (350 p.g) from cell membranes and 50 p.g of viral proteins were denatured at 100°C for 2 min in sodium dodecyl sulfate (1% sodium dodecyl sulfate-10% glycerol in 0.2 M Tris-hydrochloride, pH 6.8) and submitted to electrophoresis in 10 (Table 1) . Antibody F-12 recognized a component present in both BaEV and RD-114 virus, but only BaEV bound anti-gp antibodies C-9 and A-6 as well as antibodies D-12 and E-4. However, the two latter antibodies only bound to BaEV(M7) grown in A204 cells, whereas the reaction of the other antibodies was independent of the host cell origin of the virus. Like BaEV(M7) of bat cell origin, the BILN strain of BaEV produced by the canine FCf2th cells only reacted with antiviral antibodies A-6, C-9, and F-12 but not with antibodies D-12 and E-4 (data not shown). Since The human antigen recognized by antibodies D-12 and E-4 is probably not situated within the HLA site. We treated Hep-2 cells, which express a high amount of HLA (6), with IgG2a antibodies Mas 1532, reacting against a determinant shared by HLA-A, -B, and -C, and Mas 018 18 ,000-dalton protein in the three different preparations (Fig. 2) . The intensity of the bands indicated that the virusproducing cell membranes contained more of this antigen than the normal cells, a conclusion in accordance with the results of radioimmunoassay shown in Fig. 1 . It appeared also that the virus contained a higher proportion of the antigen than the cell membranes since only 50 ,ug of viral proteins were separated on the gel versus 350 ,ug of cellular proteins. One or two minor bands (16,000 and 13,000 daltons) were also detected in the virion polypeptides and may be due to partial degradation of the major protein. Antibody F-12, used as control, revealed a single antigen of 18,000 daltons in the viral preparation ( Fig. 2A, lane 3) , corresponding to the structural viral polypeptide already demonstrated by immunoprecipitation (5). This polypeptide was absent from the host cell membrane preparation ( Fig. 2A, lanes 1 and 2) (Table 3 ). Heated heterologous rabbit antisera raised against HeLa cells inhibited adsorption of the three viruses on HeLa cells, whereas anti-HLA antibody Mas 1532 and anti-132 microglobulin antibody Mas 018 did not decrease adsorption of BaEV or MP-MV (RD-114 virus not tested with these antibodies). Antibodies D-12 and E-4 specifically blocked BaEV adsorption, with no effect on the fixation of the two other viruses.
Adsorption of BaEV onto susceptible cells was also measured by taking advantage of the fact that virus-free cells coated from without with BaEV bind IgG2a antibody A-6, which is directed at the gp of the virion. The cell-virusantibody complexes will then bind 125I-labeled protein A. In addition, blocking of virus adsorption by anticellular antibody can be assayed by pretreating the cells with antibody E-4 before addition of the virus. Since this antibody is of the IgM class, it will not be recognized by protein A. This test confirmed that antibody E-4 prevented adsorption of both BILN and M7 viruses onto the human A204 cells but did not inhibit BaEV adsorption on the simian Vero cells or on the canine Fcf2th cells (Table 4) . (Fig. 3) b Virus adsorption on cell suspensions and titration of syncytium-forming units in the cell supernatant, as described in Table 3 . c BaEV adsorption monitored by treating the coated cells with antiviral antibody A-6, as described in Table 4 . (Fig. SB) . Surprisingly, when the virus-free canine Fcf2th cells were treated with BaEV grown on Action of antibody E-4 on productive BaEV infection. When BaEV was added to A204 cells without prior polybrene treatment, the virus was detected at the cell surface with antiviral antibody A-6 for as long as 48 h, with eventual disappearance at 72 h. If cells had been pretreated with polybrene, most of the viral gp had disappeared from the cell surface at 6 h after virus addition, probably because of virus penetration. A latent period was observed at 12 and 24 h after infection, and viral gp was again detected at 72 h, most probably on budding progeny. When A204 cells were treated simultaneously with antibody E-4 and with the virus, no virus was adsorbed onto cells without polybrene, and no infectious cycle occurred after polybrene treatment (data not shown). We then studied the action of antibody E-4 on intracellular virus production in chronically infected A204(M7) cells as well as on the release of virus particles and of soluble viral gp. In cells grown with antibody E-4 for 48 h, there was an accumulation of the internal viral polypeptide recognized by antibody F-12, and there was a slight increase of the viral gp detected by antibody A-6 (Fig. 6A) . Viral protein accumulation probably resulted from inhibition of release, since medium from the antibody-treated cultures contained fewer virus particles in the ultracentrifugation pellet (Fig. 6B) and less viral soluble gp in the supernatant (Fig. 6C) . In contrast to antibody E-4, anti-HLA antibody Mas 1532 did not modify the amount of virions and soluble gp released in the culture medium (data not shown).
We wanted to test whether production of RD-114 virus was also modified by antibody E-4. It was not possible to monitor the synthesis of RD-114 gp because of the lack of appropriate antibodies. However, antibody F-12 recognizes an internal polypeptide which is common to BaEV and RD-114 virus. When the RD-114 cells were cultivated for 48 h in the presence of antibody E-4, there was no modification of the amount of intracellular viral protein corresponding to antibody F-12, indicating that virus release was not inhibited (data not shown). DISCUSSION We have found that antibodies D-12 and E-4 defined two epitopes lying within an 18,000-dalton protein present in the membrane of human cells but not in that of other animal species. We also set up another assay for BaEV adsorption by demonstrating that target cells coated with this virus bound antibodies C-9 and A-6 which are directed at the viral gp7O. With this assay, we confirmed that prior treatment of human cells with antibody E-4 precluded BaEV adsorption. Evidence that virions and antibody D-12 competed for the same cellular site also derived from the observation that cells coated at 4°C with BaEV from dog or bat cells bound less antibody D-12 than virus-free cells.
Another indication that target sites for antibodies E-4 and D-12 are receptors for BaEV was obtained when antibody adsorption on various human cells was quantitated and was found to correlate with the number of BaEV particles that each cell type was able to adsorb. Cell suspensions directly prepared from human blood or fetal tissues possessed very low amounts of BaEV receptors, and this probably reflects the in vivo situation. Placental syncytiotrophoblastic cells bound more antibody D-12 than the other tissues tested, but this does not necessarily prove that receptor density was greater, since (13) nor from the with the virions. virus grown in human 10,000-dalton protein isolated from the spent cells did not contain these cell determinants.
The human cell determinants of BaEV coadsorbed with the virions onto animal cells, showing that BaEV could play the part of a vehicle to carry a human antigen over to an animal cell. This human antigen even appeared to be concentrated on the virions, since BaEV particles reacted more strongly with antibodies P-12 and E-4 than did cell membrane preparations of virus-free cells. Also, A204(M7) cells chronically producing BaEV reacted more strongly with antibody D-12 than did the control virus-free cells. This contrasts with feline leukemia viruses grown in human cells, which picked up HLA antigens but did not selectively concentrate HLA determinants either in the host cell or in the virions (1).
If the cell receptors were really complexed with some spikes of the viral envelope, other gp7O units must remain free for virus fixation and infection to occur, and stripping of the receptors from the particles could lead to increased chances for infectious processes to occur. On the other hand, if each cell receptor was able to bind more than one viral gp7O, a dense suspension of virus particles would tend to agglutinate and produce networks with receptor bridges because links could occur between one particle with a gp70 receptor complex and another virus particle with a free gp7O. Another possibility is that the cell epitopes described above might become integrated within the viral envelope during maturation, independently of the gp7O.
The use of monoclonal antibodies helped to further characterize the differences between BaEV and the closely related RD-114 virus as well as between their cell receptors. Two determinants of BaEV gp7O have been characterized by their reaction with antibodies A-6 and C-9 on the one hand and with antibody B-9 on the other hand (6), and we showed here that they were not recognized on RD-114 virus. However, gps of the two virions probably address overlapping or adjacent receptors, since human amnion cells infected with RD-114 virus or with BaEV were resistant to focus formation by pseudotypes of Moloney sarcoma virus with BaEV or RD114 virus envelopes, respectively (8) .
We also showed that prior adsorption of RD-114 virus on human cells decreased the cells ability of the cells to bind BaEV. However, host ranges for adsorption of the two viruses bear some differences. It had already been demonstrated that vesicular stomatitis virus pseudotypes with BaEV envelopes adsorbed to mouse and rat cells, whereas the pseudotypes with RD-114 virus did not (16 The presence of receptors on the cell membrane is necessary, but it is not the only condition for productive viral infection. For instance, we showed that mouse cells adsorb BaEV although these cells are not virus permissive, probably because they lack an integration site in their chromosome (12) . This site is present in the human chromosome 6 (11), and another cell function necessary for BaEV infection is coded by chromosome 19 (3) . Such a function may relate to the synthesis of polypeptides common to BaEV and RD-114 virus receptors, since the receptor for the latter virus is coded by human chromosome 19 (15) . It will be of interest to study whether the BaEV-specific polypeptide sequences recognized by antibodies D-12 and E-4 are also coded by the same chromosome. It will also be possible to directly test whether the presence of chromosome 19 is necessary for BaEV adsorption, since cells with acceptor sites for the virus will subsequently bind antiviral antibodies A-6 or C-9.
